Regen BioPharma Inc (RGBP)

Price$0.0001Cached quote
RGBPOTC
Loading local price history

Financial charts

Revenue

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

13 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013
Revenue$236,561$236,560$236,560$125,517$61,194$110,000$110,000$100,000$110,000$100,000$192,000$0—
Research & development$11,725$153,685$212,297$158,138$36,704$13,286$45,605$374,436$1.1M$671,095$282,295$23,867$8,394
Operating expenses$575,101$653,781$923,509$575,122—$319,317$866,785$1.5M$2.6M$3.1M$2.2M$706,354—
Operating income−$338,540−$417,221−$686,950−$339,605−$200,771−$209,317−$756,785−$1.4M−$2.5M−$3.0M−$2.0M−$706,354−$319,836
Operating margin−143.11%−176.37%−290.39%−270.56%−328.09%−190.29%−687.99%−1,425.78%−2,282.62%−2,956.96%−1,030.87%——
EBITDA−$1.1M−$566,812$1.2M$2.7M—————————
EBITDA margin−449.81%−239.61%514.02%2,113.91%—————————
Net income−$1.3M−$668,255$1.2M$2.4M−$6.8M$3.4M−$2.6M−$4.7M−$5.8M−$7.8M−$11.2M−$756,353−$355,034
Net profit margin−538.76%−282.49%488.89%1,946.77%−11,055.39%3,104.02%−2,384.71%−4,715.20%−5,308.22%−7,750.59%−5,830.81%——
Basic EPSper basic share-$0.05-$0.16$0.29$0.71-$0.00$0.00-$0.00-$0.03-$0.04-$0.06-$0.13-$0.01-$0.02
Diluted EPSper diluted share-$0.05-$0.16$0.29$0.71-$0.00$0.00-$0.00-$0.03-$0.04-$0.06-$0.13-$0.01-$0.02

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about RGBP yet. Start the conversation.

Write the first post